
CBDC
Healthcare · Biotechnology · $9.0M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Apr 30, 2019 | Time not confirmed | — | -0.02 | — |
| Jan 31, 2019 | Time not confirmed | — | -0.02 | — |
| Oct 31, 2018 | Time not confirmed | — | -0.00 | — |
| Jul 31, 2018 | Time not confirmed | — | -0.00 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.00 | — |
Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry in the United States. The company's products include transdermal, sublingual, and nasal delivery devices for dosing of cannabinoids. It also provides CBD pain cream, gel capsules, patches, and sleep tablets; and Promed, anti-aging and cosmetic…